Terms: = Liver cancer AND MALAT1, PRO1073, 378938, Q9UHZ2
87 results:
1.
Piórkowska K; Zygmunt K; Hunter W; Wróblewska K
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674413
[TBL] [Abstract] [Full Text] [Related]
2. [JAG1 affects monocytes-macrophages to reshape the pre-metastatic niche of triple-negative breast cancer through LncRNA malat1 in exosomes].
Xu M; Shi Y; Liu J; Wu M; Zhang F; He Z; Tang M
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Sep; 43(9):1525-1535. PubMed ID: 37814867
[TBL] [Abstract] [Full Text] [Related]
3. Dynamic expression of H19 and malat1 and their correlation with tumor progression biomarkers in a multistage hepatocarcinogenesis model.
El-Daly SM; El-Bana MA; Abd El-Rahman SS; Latif YA; Medhat D
Cell Biochem Funct; 2023 Apr; 41(3):331-343. PubMed ID: 36861261
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of long non-coding RNA
Liao X; Chen J; Luo D; Luo B; Huang W; Xie W
Pathol Oncol Res; 2022; 28():1610808. PubMed ID: 36685103
[No Abstract] [Full Text] [Related]
5. The contribution of malat1 gene rs3200401 and MEG3 gene rs7158663 to the risk of lung, colorectal, gastric and liver cancer.
Wang W; Xiong W; Zheng J; Jin Y; Dong L; Feng X; Ban Y; Chen B
Pathol Res Pract; 2022 Dec; 240():154212. PubMed ID: 36410173
[TBL] [Abstract] [Full Text] [Related]
6. Brain atlas for glycoprotein hormone receptors at single-transcript level.
Ryu V; Gumerova A; Korkmaz F; Kang SS; Katsel P; Miyashita S; Kannangara H; Cullen L; Chan P; Kuo T; Padilla A; Sultana F; Wizman SA; Kramskiy N; Zaidi S; Kim SM; New MI; Rosen CJ; Goosens KA; Frolinger T; Haroutunian V; Ye K; Lizneva D; Davies TF; Yuen T; Zaidi M
Elife; 2022 Sep; 11():. PubMed ID: 36052994
[TBL] [Abstract] [Full Text] [Related]
7. Gene expression profile of human colorectal cancer identified NKTR as a biomarker for liver metastasis.
Bai R; Shi Z; Li D; Zhou D; Ge WT; Zheng S
Aging (Albany NY); 2022 Aug; 14(16):6656-6667. PubMed ID: 36006421
[TBL] [Abstract] [Full Text] [Related]
8. High-glucose-induced hyperosmolar stress sensitizes HepG2 cell lines to sorafenib.
Esawie M; L Louka M; Hasanin AH; El-Kholy AA; Said Ali H
Gene; 2022 Nov; 844():146828. PubMed ID: 35998844
[TBL] [Abstract] [Full Text] [Related]
9. malat1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy.
Matuszyk J
Mol Med; 2022 Aug; 28(1):89. PubMed ID: 35922756
[TBL] [Abstract] [Full Text] [Related]
10. Associations of malat1 and its functional single nucleotide polymorphisms with cancer.
Cao L; Yan G; Yu S; Li F; Su Z; Hou X; Xiao J; Tian T
Pathol Res Pract; 2022 Aug; 236():153988. PubMed ID: 35759938
[TBL] [Abstract] [Full Text] [Related]
11. lncRNA malat1 promotes HCC metastasis through the peripheral vascular infiltration via miRNA-613: a primary study using contrast ultrasound.
Zhou D; Wang Y; Hu H; Liu H; Deng J; Li L; Zheng C
World J Surg Oncol; 2022 Jun; 20(1):203. PubMed ID: 35706002
[TBL] [Abstract] [Full Text] [Related]
12. High Expression of EZH2 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma.
Chen Z; Lin X; Wan Z; Xiao M; Ding C; Wan P; Li Q; Zheng S
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627262
[TBL] [Abstract] [Full Text] [Related]
13. The bromodomain inhibitor JQ1 up-regulates the long non-coding RNA malat1 in cultured human hepatic carcinoma cells.
Choi HI; An GY; Yoo E; Baek M; Binas B; Chai JC; Lee YS; Jung KH; Chai YG
Sci Rep; 2022 May; 12(1):7779. PubMed ID: 35546353
[TBL] [Abstract] [Full Text] [Related]
14. A long non-coding RNA-based signature predicts early recurrence in hepatocellular carcinoma.
He S; Li JF; Tian H; Sang Y; Yang XJ; Guo GX; Yang JE
Cancer Biomark; 2022; 34(2):309-318. PubMed ID: 34957996
[TBL] [Abstract] [Full Text] [Related]
15. Intelligent Bio-Responsive Fluorescent Au-shRNA Complexes for Regulated Autophagy and Effective cancer Bioimaging and Therapeutics.
Cai W; Yin L; Jiang H; Weizmann Y; Wang X
Biosensors (Basel); 2021 Oct; 11(11):. PubMed ID: 34821640
[TBL] [Abstract] [Full Text] [Related]
16. An Integrated Transcriptomics and Proteomics Analysis Implicates lncRNA malat1 in the Regulation of Lipid Metabolism.
Wang H; Zhang Y; Guan X; Li X; Zhao Z; Gao Y; Zhang X; Chen R
Mol Cell Proteomics; 2021; 20():100141. PubMed ID: 34478876
[TBL] [Abstract] [Full Text] [Related]
17. miRNA and long non-coding RNA transcriptional expression in hepatocellular carcinoma cell line-secreted extracellular vesicles.
Cabiati M; Salvadori C; Basta G; Del Turco S; Aretini P; Cecchettini A; Del Ry S
Clin Exp Med; 2022 May; 22(2):245-255. PubMed ID: 34319456
[TBL] [Abstract] [Full Text] [Related]
18. Early detection of hepatocellular carcinoma via liquid biopsy: panel of small extracellular vesicle-derived long noncoding RNAs identified as markers.
Kim SS; Baek GO; Son JA; Ahn HR; Yoon MK; Cho HJ; Yoon JH; Nam SW; Cheong JY; Eun JW
Mol Oncol; 2021 Oct; 15(10):2715-2731. PubMed ID: 34185961
[TBL] [Abstract] [Full Text] [Related]
19. malat1: A Promising Therapeutic Target for the Treatment of Metastatic Colorectal cancer.
Uthman YA; Ibrahim KG; Abubakar B; Bello MB; Malami I; Imam MU; Qusty N; Cruz-Martins N; Batiha GE; Abubakar MB
Biochem Pharmacol; 2021 Aug; 190():114657. PubMed ID: 34144008
[TBL] [Abstract] [Full Text] [Related]
20. Identification of a stool long non-coding RNAs panel as a potential biomarker for early detection of colorectal cancer.
Gharib E; Nazemalhosseini-Mojarad E; Baghdar K; Nayeri Z; Sadeghi H; Rezasoltani S; Jamshidi-Fard A; Larki P; Sadeghi A; Hashemi M; Asadzadeh Aghdaei H
J Clin Lab Anal; 2021 Feb; 35(2):e23601. PubMed ID: 33094859
[TBL] [Abstract] [Full Text] [Related]
[Next]
